Dear All,
We received the attached NHSi patient safety alert yesterday and have been discussing it internally.
Within the NHSi hyperlink (https://improvement.nhs.uk/resources/resources-to-support-safe-and-timely-management-of-hyperkalaemia)
there is a signpost to ‘Clinical Practice Guidelines for Treatment of Acute Hyperkalaemia in adults’ (UK Renal Assoc, March 2014).
On opening that document, on page 4 there is a clear stipulation from the ACB as follows:
We feel that it is disappointing that pseudohyperkalaemia is not mentioned in the Patient Safety Alert and are wondering what other colleagues’ views are?
Kind Regards,
Carys Lippiatt
|
Dr Carys Lippiatt PhD FRCPath Clinical Lead for Specialist Laboratory Medicine Clinical Lead for Pathology Research and Innovation Leeds Teaching Hospitals NHS Trust Beckett Street, Leeds LS9 7TF (
0113 20 64852 | *
[log in to unmask]
|